Standard BioTools (LAB) expects fourth quarter 2024 revenue of approximately $46.5M and full year 2024 revenue of approximately $174M. “The ...
Standard BioTools plans to report its fourth quarter and full year 2024 financial results later this quarter, at which time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback